Immunohistological Study of Lymphoblastic Lymphoma
نویسندگان
چکیده
منابع مشابه
cute Lymphoblastic Leukemia ( Adult ) Including Lymphoblastic lymphoma
ALL is now diagnosed and classified according to the WHO classification of neoplastic disease of hematopoietic and lymphoid tissues [2]. ALL is defined by the presence of ≥ 20% lymphoblasts in the marrow or peripheral blood. This is a change from the previous FAB classification, which required ≥ 30% blasts [3]. The relationship between ALL and lymphoblastic lymphoma remains unclear. Under the W...
متن کاملB-acute lymphoblastic leukemia/lymphoblastic lymphoma.
OBJECTIVES This session of the 2013 Society of Hematopathology/European Association for Haematopathology Workshop was dedicated to B-acute lymphoblastic leukemia (B-ALL)/lymphoblastic lymphoma (LBL) with recurrent translocations and not otherwise specified. METHODS In this review, we summarize the cases discussed during the workshop, review the pertinent and most recent literature on the resp...
متن کاملT-lymphoblastic leukemia/lymphoma.
OBJECTIVES To review important concepts from the 2013 Society for Hematopathology/European Association for Haematopathology Workshop session on T-acute lymphoblastic leukemia/T-lymphoblastic lymphoma (T-ALL/T-LBL). METHODS Twenty-one submitted cases are reviewed and summarized, with emphasis on key diagnostic or biologic points, and supplemented with relevant literature citations. RESULTS E...
متن کاملLymphoblastic lymphoma of the palate.
Lymphoblastic lymphomas are neoplasms of immature or precursor lymphoid cells with no or limited bone marrow involvement, whose clinical presentation varies according to the immunophenotype. While mediastinal involvement is predominant in T-lymphoblastic lymphomas, B-lymphoblastic lymphomas frequently involve nodal sites. Extranodal presentation of B-lymphoblastic lymphomas is extremely rare. W...
متن کاملThe chemotherapy of lymphoblastic lymphoma.
Thirty-two patients treated on consecutive Southwest Oncology Group (SWOG) protocols for malignant lymphoma were subsequently diagnosed as having lymphoblastic lymphoma. Combination chemistry, usually adriamycin-based, produced complete responses (CR) in 17 patients (53%). Median survival was 15 mo. Patients achieving a CR survival significantly longer than patients with partial or no response ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Japan Society of the Reticuloendothelial System
سال: 1987
ISSN: 1883-6801,0386-9725
DOI: 10.3960/jslrt1961.27.285